In all the three tumour types, a hypermethylation phenotype similar to that described for central CS was identified, suggesting a common mechanism linking gain of function in the IDH enzyme associated with reduced demethylation, possibly through inhibition of the TET family of oxygenases15. Here, IDH2 is linked to neoplasm.